Treatment of latent tuberculosis

Details for Australian Patent Application No. 2005242138 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Andries, Koenraad Jozef Lodewijk Marcel; Koul, Anil

Agent Shelston IP

Pub. Number AU-B-2005242138

Priority 05105008.6 08.06.05 EP; 04078529.7 24.12.04 EP

Filing date 7 December 2005

Wipo publication date 13 July 2006

Acceptance publication date 26 May 2011

International Classifications

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4745 (2006.01)

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

22 December 2005 Complete Application Filed

  Priority application(s): 05105008.6 08.06.05 EP; 04078529.7 24.12.04 EP

13 July 2006 Application Open to Public Inspection

  Published as AU-B-2005242138

26 May 2011 Application Accepted

  Published as AU-B-2005242138

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005242139-Pressure sensitive cable device for monitoring rock and soil displacement

2005242137-Safety needle medical bearing devices